Jiro Kikuchi
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 15
- Histone Deacetylase Inhibitors Research 13
- Ubiquitin and proteasome pathways 10
- Glycosylation and Glycoproteins Research 9
- Epigenetics and DNA Methylation 6
- Hematology 33
- Multiple Myeloma Research and Treatments 20
- Co-authors
- Yusuke Furukawa (74 shared papers)Taeko Wada (17 shared papers)Mitsuru Nakamura (13 shared papers)Satsuki Iwase (12 shared papers)Yasuhiko Kano (10 shared papers)Yasuhito Terui (7 shared papers)Daisuke Koyama (11 shared papers)Hisashi Yamada (6 shared papers)
- Journals
- Blood (7 papers)Journal of Biological Chemistry (7 papers)Oncogene (6 papers)Leukemia (5 papers)PLoS ONE (4 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Jiro Kikuchi
86 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 104
- Hematology 659
- Oncology 545
- Molecular Biology 1.4k
- Immunology and Allergy 94
- Immunology 318
Countries citing papers authored by Jiro Kikuchi
This map shows the geographic impact of Jiro Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Kikuchi more than expected).
Fields of papers citing papers by Jiro Kikuchi
This network shows the impact of papers produced by Jiro Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Kikuchi. The network helps show where Jiro Kikuchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiro Kikuchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 153 | |
| 2 | 2010 | 112 | |
| 3 | 2000 | 98 | |
| 4 | 2000 | 84 | |
| 5 | 2010 | 83 | |
| 6 | 2015 | 83 | |
| 7 | 2012 | 73 | |
| 8 | 1997 | 71 | |
| 9 | 2012 | 66 | |
| 10 | 2009 | 60 | |
| 11 | 1996 | 58 | |
| 12 | 2013 | 56 | |
| 13 | 2015 | 52 | |
| 14 | 1995 | 51 | |
| 15 | 2019 | 51 | |
| 16 | 2016 | 46 | |
| 17 | 2015 | 44 | |
| 18 | 2000 | 43 | |
| 19 | 2020 | 40 | |
| 20 | Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells. | 1998 | 40 |
About Jiro Kikuchi
Jiro Kikuchi is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Immunology and Allergy, having authored 90 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (15 papers), Histone Deacetylase Inhibitors Research (13 papers), Ubiquitin and proteasome pathways (10 papers), Glycosylation and Glycoproteins Research (9 papers), Peptidase Inhibition and Analysis (8 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Hematology (659 citations), Oncology (545 citations), Molecular Biology (1.4k citations), Immunology and Allergy (94 citations) and Immunology (318 citations). Jiro Kikuchi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yusuke Furukawa, Taeko Wada, Mitsuru Nakamura, Satsuki Iwase, Yasuhiko Kano, Yasuhito Terui, Daisuke Koyama, Hisashi Yamada, Michio Matsuda and Tohru Izumi. Their work appears in journals such as Blood, Journal of Biological Chemistry, Oncogene, Leukemia and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.